Suchergebnisse - "Pouessel, Damien"

PubPharm (106)

1

Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy : TROPHY-U-01 Cohort 3

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Grivas, P. | Pouessel, D. | Park, C. | +17

2

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma

enthalten in: The New England journal of medicine | 2024

von Choueiri, T. | Tomczak, P. | Park, S. | +131

3

Derazantinib alone and with atezolizumab in metastatic urothelial carcinoma with activating FGFR aberrations

enthalten in: JNCI cancer spectrum | 2024

von Necchi, A. | Ramlau, R. | Falcón González, A. | +19

4

Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches : An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials

enthalten in: European urology | 2024

von Cavillon, A. | Pouessel, D. | Houédé, N. | +7

CommentIn: Eur Urol. 2023 Jul;84(1):e22-e23. - PMID 37120335

5

Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations : cohort 2 of the randomized phase III THOR trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Siefker-Radtke, A. | Matsubara, N. | Park, S. | +113

6

Skin toxicity of enfortumab vedotin : Proposal of a specific management algorithm

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Ingen-Housz-Oro, S. | Elshot, Y. | Segura, S. | +12

7

Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma

enthalten in: The New England journal of medicine | 2023

von Loriot, Y. | Matsubara, N. | Park, S. | +116

8

Hypofractionated Stereotactic Re-irradiation and  Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma : STERIMGLI Phase I Results

enthalten in: The oncologist | 2023

von Pouessel, D. | Ken, S. | Gouaze-Andersson, V. | +15

9

Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy

enthalten in: BJU international | 2023

von Claps, F. | van de Kamp, M. | Mayr, R. | +29

10

The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer : A Multi-Center, Multi-Laboratory Analysis

enthalten in: International journal of surgical pathology | 2023

von Mertens, L. | Claps, F. | Mayr, R. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]